
.
Eindhoven Area, Netherlands

.
Eindhoven Area, Netherlands
David R. Hampton, PhD is an internationally active scientist and entrepreneur, creating innovative products for cardiac arrest, myocardial infarction, and stroke patients through global clinical research and business partnerships.
Dr. Hampton developed the first commercial quantitative EEG and brainmapping systems for neurology and psychiatry, and later led European and US teams developing interpretive ECG systems and lifesaving “shock predictive” technologies for cardiac arrest. As Research Director for Medtronic Physio-Control, he was awarded became a Bakken Fellow, Medtronic's highest scientific recognition, for his work in acute myocardial infarction diagnostics and alerting.
Most recently, Dr. Hampton completed an MPhil degree (with distinction) at the Institute for Biotechnology at the University of Cambridge (UK). His thesis work defines business models for creation of spin-out companies from corporate projects, and he was co-founder of Camstent, Ltd, a company developing biofilm-resistant coatings. He is a senior associate with Cambridge, coordinating lectures in Medical Diagnostics and Devices.
He currently on expatriate assignment, leading Medtronic’s development of implantable monitoring and alerting systems in the Netherlands, focused on cross-border opportunities to create innovative businesses at the interface of biotechnology, clinical informatics, and medical devices.
Innovation management: Medical diagnostics, clinical therapeutic devices, medical informatics, clinical study management. Commercial diagnostic systems, biotechnology, biologics, biosensors, biotherapeutics, and bioinformatics;
Global business management: ex-patriate UK and Netherlands. Consultant, writer, lecturer on medical technology, clinical information management, global entrepreneurship, team leadership
(Medical Devices industry)
July 2006 — Present (3 years 1 month)
(Medical Devices industry)
November 2008 — June 2009 (8 months)
(Public Company; MDT; Medical Devices industry)
November 2006 — November 2008 (2 years 1 month)
Led product planning, business analysis, technology research, and new product teams for a new cardiac monitoring / alerting device business. Member of the senior leadership team
(Public Company; MDT; Medical Devices industry)
January 1999 — December 2003 (5 years)
(Public Company; 501-1000 employees; Information Technology and Services industry)
January 1995 — December 1999 (5 years)
(Public Company; LLY; Pharmaceuticals industry)
January 1991 — December 1994 (4 years)
(Public Company; 501-1000 employees; Medical Devices industry)
January 1988 — December 1990 (3 years)
(Privately Held; Medical Devices industry)
June 1983 — October 1987 (4 years 5 months)
Cert Mgt , Management Science and Investment , 2008 — 2009
MPhil , Business / Biotechnology , 2005 — 2006
PhD , Biomedical Engineerting , 1979 — 1982
MS , Biomedical Engineering , 1976 — 1979
BA , Physics - Applied Mathematics , 1972 — 1976
Fellow: Medtronic Bakken Society
Fellow: American Institute for Medical and Biological Engineering
Fellow: Cambridge Philosophical Society
Senior Member: IEEE Engineering in Medicine and Biology Society
Emeritus Board Member: International Society for Computerized Electrocardiology
Editorial Board: Journal of Electrocardiography
Professional Member: American Heart Association
Professional Member: European Resuscitation Council
Professional Member: European Society of Cardiology
Professional Member: National Association of EMS Physicians
Advisory Board Member: University of Washington Medical Engineering Certificate Program
Advisory Board Member: Center for Information Technology Research in the Interest of Society, University of California
Member: Puget Sound Stroke Interest Group